Nucleobindin-2 mRNA (NUCB2 mRNA) (NUCB2 mRNA)

Nucleobindin-2 (NUCB2) mRNA is the transcript encoding the NUCB2 protein, a calcium-binding precursor that is proteolytically processed into the bioactive peptide Nesfatin-1. Primarily synthesized in the hypothalamic nuclei, NUCB2/Nesfatin-1 acts as a potent anorexigenic signal, regulating food intake and energy expenditure independently of the leptin pathway (Oh-I et al., Nature, 2006). Beyond its central role in appetite suppression, NUCB2 mRNA expression is found in peripheral tissues such as the pancreas, stomach, and adipose tissue, where it influences glucose-induced insulin secretion and lipid metabolism (Stengel et al., 2011). In the context of disease, NUCB2 is implicated in metabolic disorders like obesity and type 2 diabetes, where its downregulation may contribute to hyperphagia. Conversely, NUCB2 overexpression has been observed in several malignancies, including prostate and breast cancers, where it promotes tumor cell proliferation and migration (Zhang et al., 2014). While no clinical drugs currently target NUCB2 mRNA directly, it remains a significant subject of research for RNA-based therapeutics, including antisense oligonucleotides and mRNA-based delivery systems aimed at modulating metabolic and oncogenic pathways.

Other names

Nesfatin-1 precursor mRNANEFA mRNADNA-binding protein 24 mRNANUCB2 transcript

Antisense inhibition of translation; RNA interference-mediated degradation; mRNA-based protein replacement therapy